Loke J - Search Results

1

Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.

Loke J, MacLennan DH. Loke J, et al. Am J Med. 1998 May;104(5):470-86. doi: 10.1016/s0002-9343(98)00108-9. Am J Med. 1998. PMID: 9626031 Review. No abstract available.

2

Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.

Kraeva N, Riazi S, Loke J, Frodis W, Crossan ML, Nolan K, Kraev A, Maclennan DH. Kraeva N, et al. Among authors: loke j. Can J Anaesth. 2011 Jun;58(6):504-13. doi: 10.1007/s12630-011-9494-6. Epub 2011 Mar 31. Can J Anaesth. 2011. PMID: 21455645

3

Protocol for the sequence analysis of ryanodine receptor subtype 1 gene transcripts from human leukocytes.

Kraev N, Loke JC, Kraev A, MacLennan DH. Kraev N, et al. Anesthesiology. 2003 Aug;99(2):289-96. doi: 10.1097/00000542-200308000-00010. Anesthesiology. 2003. PMID: 12883401

4

Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.

Loke JC, Kraev N, Sharma P, Du G, Patel L, Kraev A, MacLennan DH. Loke JC, et al. Anesthesiology. 2003 Aug;99(2):297-302. doi: 10.1097/00000542-200308000-00011. Anesthesiology. 2003. PMID: 12883402

5

Bayesian modeling of muscle biopsy contracture testing for malignant hyperthermia susceptibility.

Loke JC, MacLennan DH. Loke JC, et al. Anesthesiology. 1998 Mar;88(3):589-600. doi: 10.1097/00000542-199803000-00007. Anesthesiology. 1998. PMID: 9523800

6

Low-dose intrathecal local anesthetic does not increase the threshold current for the epidural stimulation test: a prospective observational trial of neuraxial analgesia in labouring women.

Carvalho JC, Khemka R, Loke J, Tsui BC. Carvalho JC, et al. Among authors: loke j. Can J Anaesth. 2015 Mar;62(3):265-70. doi: 10.1007/s12630-014-0291-x. Epub 2014 Dec 11. Can J Anaesth. 2015. PMID: 25501494

7

Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.

Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Roméro N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J. Monnier N, et al. Among authors: loke j. Hum Mutat. 2005 Nov;26(5):413-25. doi: 10.1002/humu.20231. Hum Mutat. 2005. PMID: 16163667

8

Insights into the unusual alpha adrenoceptor subtype in dog saphenous vein using phenoxybenzamine.

Low AM, Lu-Chao H, Loke JC, Kwan CY, Daniel EE. Low AM, et al. Among authors: loke jc. J Pharmacol Exp Ther. 1999 Jan;288(1):148-56. J Pharmacol Exp Ther. 1999. PMID: 9862765

9

Sensitivity to protein kinase C inhibitors of nicardipine-insensitive component of high K+ contracture in rat and guinea-pig aorta.

Low AM, Loke JC, Kwan CY, Daniel EE. Low AM, et al. Among authors: loke jc. Br J Pharmacol. 1994 Jun;112(2):604-10. doi: 10.1111/j.1476-5381.1994.tb13117.x. Br J Pharmacol. 1994. PMID: 7521261 Free PMC article.

10

Cost of anaesthesia.

Loke J, Shearer WA. Loke J, et al. Can J Anaesth. 1993 May;40(5 Pt 1):472-4. doi: 10.1007/BF03009526. Can J Anaesth. 1993. PMID: 8513535 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results